Michael S. Ominsky

Ascendis Pharma (Denmark) — Denmark

Medicine · Health Sciences

49h-index10.2kcitations120works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and osteoporosis research(69), Bone Metabolism and Diseases(64), Bone health and treatments(47), Connective tissue disorders research(16), Orthopaedic implants and arthroplasty(11)

Publications119 total

Improved Skeletal Dynamics in Adults Treated with Palopegteriparatide for Chronic Hypoparathyroidism: 214-Week Results from the Phase 2 PaTH Forward Trial
Endocrine Abstracts·2026
Long-Term Efficacy and Safety of Palopegteriparatide Treatment in Adults With Chronic Hypoparathyroidism: 4-Year Results From the Phase 2 PaTH Forward Trial
Endocrine Abstracts·2026
Improvements in Lower Extremity Alignment are Associated with Physical Functioning in Children with Achondroplasia Treated with Navepegritide: 52-Week Results from the ApproaCH Trial
Endocrine Abstracts·2026
Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial
Journal of Bone and Mineral Research·2026Open Access
Once-Weekly Navepegritide in Children With Achondroplasia
JAMA Pediatrics·2025· 1 citedOpen Access
Efficacy and Safety of Palopegteriparatide Treatment in Adults With Hypoparathyroidism: 3-Year Results From the Phase 3 PaTHway Trial
Canadian Journal of Diabetes·2025
Long-Term Efficacy and Safety of Palopegteriparatide Treatment in Adults With Chronic Hypoparathyroidism: 4-Year Results From the Phase 2 PaTH Forward Trial
Canadian Journal of Diabetes·2025
Long-term efficacy and safety of palopegteriparatide treatment in adults with chronic hypoparathyroidism: 4-year results from the phase 2 PaTH forward trial
Annales d Endocrinologie·2025
High-dose romosozumab promoted bone regeneration of critical-size ulnar defect filled with demineralized bone matrix in nonhuman primates
Journal of Orthopaedic Translation·2025· 2 citedOpen Access
Effects of navepegritide on bone morphometry in children with achondroplasia: 52-week results from the approach clinical trial
Endocrine Abstracts·2025
Long-term efficacy and safety of palopegteriparatide treatment in adults with chronic hypoparathyroidism: 4-year results from the phase 2 path forward trial
Endocrine Abstracts·2025
Palopegteriparatide Improves Skeletal Dynamics in Adults With Chronic Hypoparathyroidism: 162-week Results From the Phase 2 PaTH Forward Trial
Osteologie/Osteology·2025· 2 cited
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 pathway trial
Endocrine Abstracts·2025· 1 cited
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway trial
Annales d Endocrinologie·2024Open Access
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
Journal of Bone and Mineral Research·2024· 20 citedOpen Access
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway trial
Endocrine Abstracts·2024· 1 cited
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial
Advances in Therapy·2024· 23 citedOpen Access
Improved Skeletal Dynamics in Adults Treated With Palopegteriparatide for Hypoparathyroidism: 52-Week Analysis of Phase 3 PaTHway Trial
Osteologie/Osteology·2024· 1 cited
Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone
Journal of Bone and Joint Surgery·2023· 12 cited
Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse
Frontiers in Genetics·2021· 14 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Hua Zhu Ke(22), Paul J. Kostenuik(21), Marina Stolina(20), Xiaodong Li(17), Frank Asuncion(17), Qing‐Tian Niu(14), Denise Dwyer(13), W. Scott Simonet(13), Mario Grisanti(11), Rogely Boyce(10), Mauricio Barrero(8), Kelly Warmington(8), Chris Pászty(8), Ian Pyrah(8), William G. Richards(7), Susan Y. Smith(7), Chun-Ya Han(7), David L. Lacey(6), Jacquelin Jolette(6), Sean Morony(5)